GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangxi Xinganjiang Pharmaceutical Co Ltd (BJSE:873167) » Definitions » Revenue

Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) Revenue : ¥187.1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Jiangxi Xinganjiang Pharmaceutical Co Revenue?

Jiangxi Xinganjiang Pharmaceutical Co's revenue for the three months ended in Mar. 2024 was ¥39.9 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥187.1 Mil. Jiangxi Xinganjiang Pharmaceutical Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.56. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.66.

Warning Sign:

Jiangxi Xinganjiang Pharmaceutical Co Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Jiangxi Xinganjiang Pharmaceutical Co was -36.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -4.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 8 years, Jiangxi Xinganjiang Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 9.20% per year. The lowest was -16.10% per year. And the median was 1.80% per year.


Jiangxi Xinganjiang Pharmaceutical Co Revenue Historical Data

The historical data trend for Jiangxi Xinganjiang Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Xinganjiang Pharmaceutical Co Revenue Chart

Jiangxi Xinganjiang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial 163.00 182.64 207.91 211.15 216.48

Jiangxi Xinganjiang Pharmaceutical Co Quarterly Data
Jun18 Dec18 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.22 54.14 39.68 53.44 39.85

Competitive Comparison of Jiangxi Xinganjiang Pharmaceutical Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangxi Xinganjiang Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangxi Xinganjiang Pharmaceutical Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangxi Xinganjiang Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Jiangxi Xinganjiang Pharmaceutical Co's Revenue falls into.



Jiangxi Xinganjiang Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥187.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangxi Xinganjiang Pharmaceutical Co  (BJSE:873167) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Jiangxi Xinganjiang Pharmaceutical Co Revenue Related Terms

Thank you for viewing the detailed overview of Jiangxi Xinganjiang Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) Business Description

Traded in Other Exchanges
N/A
Address
No. 36 Yunzhang Road, Jizhou District, Jiangxi Province, Ji'an City, CHN, 343000
Jiangxi Xinganjiang Pharmaceutical Co Ltd research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, Phenaminokamin Tablets.

Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) Headlines

No Headlines